5 Wegovy Alternatives to Consider for Weight Loss - GoodRx (2024)

Key takeaways:

  • Wegovy (semaglutide) is a once-weekly injection for weight loss. It’s considered a glucagon-like peptide-1 (GLP-1) agonist. Wegovy is a popular medication in high demand, so it may be hard to fill at the pharmacy.

  • There are two injectable Wegovy alternatives: Zepbound (tirzepatide) and Saxenda (liraglutide). Zepbound is also a weekly injection, while Saxenda is a daily injection.

  • There are also oral weight-loss medications available. Examples include Contrave (naltrexone / bupropion), Qsymia (phentermine / topiramate ER), and Xenical (orlistat).

  • If you’re having difficulty filling your Wegovy prescription, your prescriber can help you navigate potential alternatives. They’ll consider your health goals, preferences, and other factors.

Table of contents

Zepbound

Saxenda

Contrave

Qsymia

Xenical

Shortage status

Bottom line

References

5 Wegovy Alternatives to Consider for Weight Loss - GoodRx (1)

Wegovy (semaglutide) belongs to a growing group of medications called glucagon-like peptide-1 (GLP-1) agonists. It’s given as a once-weekly injection for weight loss. Because it works well to help people lose weight, Wegovy is often difficult to find due to shortages.

So, what are your options if you can’t fill your Wegovy prescription? Below, we cover five injectable and oral Wegovy alternatives your prescriber may consider for you.

1. Zepbound

Compared with the other Wegovy alternatives, Zepbound (tirzepatide) has a few similarities with Wegovy. It’s also a once-weekly injection, and it works in a similar but slightly different way. Wegovy mimics GLP-1, a gut hormone involved in digestion and appetite. But Zepbound also mimics a second hormone called glucose-dependent insulinotropic polypeptide (GIP).

Because of how it works, Zepbound may result in greater weight loss compared with Wegovy. The two medications are being studied in a head-to-head trial to confirm if this is true. However, Wegovy is also approved to lower the risk of serious cardiovascular problems in certain people. Zepbound isn’t approved for this yet, but it could be in the future.

Zepbound and Wegovy are both approved for adults. Wegovy is also approved for adolescents ages 12 and older. So, adolescents looking for a Wegovy alternative may need to consider a different option than Zepbound for now.

As with Wegovy, the demand for Zepbound is high. As of May 2024, most Zepbound doses have limited availability through June 2024. Tirzepatide, the main ingredient in Zepbound, is also sold under the brand name Mounjaro for Type 2 diabetes. Most Mounjaro doses also have limited availability.

2. Saxenda

Saxenda (liraglutide) is another injectable GLP-1 agonist medication. It works the same way as Wegovy, but Saxenda needs to be injected every day. And it doesn’t have the same cardiovascular risk reduction approval. But like Wegovy, Saxenda is also approved for adults and adolescents ages 12 and older.

If you switch from Wegovy to Saxenda, keep in mind that the injection pens work differently. Wegovy comes in a single-use injection pen, while Saxenda comes in a multidose pen. That means you’ll use the Saxenda pen for multiple doses, instead of throwing it away after you use it.

With Saxenda, you may not lose as much weight as you might with Wegovy. In a study comparing the two medications, people receiving Saxenda lost about 6% of their starting body weight, while people receiving Wegovy lost close to 16%.

Saxenda and Wegovy are made by the same manufacturer. Similarly, Saxenda is also in short supply.

5 Wegovy Alternatives to Consider for Weight Loss - GoodRx (2)

How to save using GoodRx

5 Wegovy Alternatives to Consider for Weight Loss - GoodRx (3)

1. Compare PricesSpecify your dosage and quantity to find out exactly how much you can save.

5 Wegovy Alternatives to Consider for Weight Loss - GoodRx (4)

2. Select your free couponYou can use the displayed coupon, or compare prices at other pharmacies near you.

5 Wegovy Alternatives to Consider for Weight Loss - GoodRx (5)

3. Show coupon to your pharmacistPresent your printed or electronic coupon when you pick up your prescription.

Get free coupon for Wegovy

3. Contrave

If you’re looking for an oral weight-loss option, your prescriber may consider Contrave. It’s an oral pill that contains two medications — naltrexone and bupropion — that work together to reduce hunger and manage cravings. Because of how it works, Contrave can be a good option if you experience emotional eating.

After the first week, you’ll take Contrave twice a day. The amount of weight loss people see with Contrave is usually 5% to 8% of their starting body weight. As with Wegovy, you may experience side effects such as nausea and vomiting, constipation, and diarrhea. But dry mouth, trouble sleeping, and higher blood pressure are also possible with Contrave.

Contrave may not be safe for certain people, including those with unmanaged high blood pressure and seizure disorders. Contrave can also interact with other medications, such as opioid medications used for pain. Review your full medication list and health history with your healthcare team before starting Contrave.

WHAT TO READ NEXT

Popular stories this week

5 Wegovy Alternatives to Consider for Weight Loss - GoodRx (6)

How Much Does Wegovy Cost Without Insurance?

5 Wegovy Alternatives to Consider for Weight Loss - GoodRx (8)

5 Tips for Injecting Wegovy

5 Wegovy Alternatives to Consider for Weight Loss - GoodRx (9)

I’m on Wegovy, So Why Am I Not Losing Weight?

View more

4. Qsymia

Another oral option is Qsymia (phentermine / topiramate ER). Qsymia is also a combination tablet. Each tablet contains phentermine (a stimulant) and topiramate (a seizure medication). Both of these medications lower your appetite to help you lose weight.

Qsymia is taken once a day in the morning. As with Wegovy, you’ll typically start at a low dose and work your way up. Depending on which dose they take long term, most people lose 5% to 10% of their body weight with Qsymia. This is similar to the potential weight loss with Contrave but less than with Wegovy.

Qsymia also has different side effects, risks, and interactions to consider. Common side effects include dry mouth, constipation, and feelings of numbness and tingling. You should typically avoid Qsymia if you have certain health conditions, including glaucoma or hyperthyroidism.

Qsymia is the only weight-loss medication with a special risk management program. This is because it can harm a growing fetus. If you’re able to get pregnant, you need a negative pregnancy test before starting Qsymia. Monthly pregnancy tests and the use of effective birth control are also required to manage this risk.

5. Xenical

Xenical (orlistat) is an oral capsule that’s taken for weight loss. Xenical requires a prescription. But its active ingredient is also available over the counter (OTC) at a lower dose (sold as Alli).

Xenical helps people lose weight by blocking the body’s ability to absorb fat when you eat. Because of this, it should be taken with meals that contain fat. Unfortunately, this also results in unpleasant side effects — such as loose, oily, or fatty stools; gas; and oily spotting on underwear.

One study found that after taking Xenical for one year, people lost an average of 8.5% of their starting body weight. Again, this is similar to the potential weight loss with other oral options but less than with Wegovy.

Since Xenical blocks fat absorption, it can interfere with your ability to absorb certain vitamins from your food. So, your prescriber may recommend adding a multivitamin. Xenical can also interact with other medications that you take by mouth, such as thyroid pills. In this case, you may need to take your other medications at a different time from when you take Xenical.

When will the Wegovy shortage be resolved?

The short answer: It’s not clear. Wegovy’s manufacturer has been working to boost production to keep up with demand. This is not an easy task, since it’s estimated that at least 25,000 people start taking Wegovy every week in the U.S.

Lower Wegovy doses may be more difficult to find since the manufacturer isn’t shipping as many. This is to manage the number of new people starting Wegovy — who typically take lower doses — ensuring that others who’ve already been taking it can continue treatment.

Given the popularity of medications such as Wegovy, it may be difficult to find alternatives that aren’t also in short supply. If your pharmacy doesn’t have your dose in stock, try calling around to other pharmacies in your area. If you’re not having any luck, your prescriber can work with you to come up with the best course of action.

The bottom line

Wegovy (semaglutide) is an FDA-approved medication for weight loss. Due to increased demand, it may be difficult to find at your usual pharmacy. So, you may be looking for potential Wegovy alternatives.

Zepbound (tirzepatide) and Saxenda (liraglutide) work in a similar way as Wegovy. But, they may also have limited availability. Weight-loss pills, such as Contrave (naltrexone / bupropion) and Qsymia (phentermine / topiramate ER), are available but may not result in as much weight loss.

These Wegovy alternatives are all approved for weight loss or management. But, they work differently in your body and lead to varying amounts of weight loss. Your prescriber can work with you to determine which of these options may work best for you.

View All References (14)

expand_more

ClinicalTrials.gov. (2024). A study of tirzepatide (LY3298176) on the reduction on morbidity and mortality in adults with obesity (SURMOUNT-MMO). U.S. National Library of Medicine.

FDA Drug Shortages. (2024). Liraglutide injection. U.S. Food & Drug Administration.

FDA Drug Shortages. (2024). Semaglutide injection. U.S. Food & Drug Administration.

FDA Drug Shortages. (2024). Tirzepatide injection. U.S. Food & Drug Administration.

Finer, N., et. al. (2000). One-year treatment of obesity: A randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor. International Journal of Obesity and Related Metabolic Disorders.

Greenway, F. L., et. al. (2019). A randomized, double-blind, placebo-controlled study of Gelesis100: A novel nonsystemic oral hydrogel for weight loss. Obesity.

H2-Pharma LLC. (2023). Orlistat- orlistat capsule [package insert].

Melson, E., et al. (2024). What is the pipeline for future medications for obesity? International Journal of Obesity.

Nalpropion Pharmaceuticals LLC. (2023). Contrave extended-release- naltrexone hydrochloride and bupropion hydrochloride tablet, extended release [package insert].

Novo Nordisk. (2024). Updates about Wegovy.

Rubino, D. M., et al. (2022). Effect of weekly subcutaneous semaglutide vs daily liraglutide on body weight in adults with overweight or obesity without diabetes: The STEP 8 randomized clinical trial. JAMA.

Sherman, M. M., et al. (2016). Naltrexone/bupropion ER (Contrave): Newly approved treatment option for chronic weight management in obese adults. Pharmacy and Therapeutics.

U.S. Food & Drug Administration, Center for Devices and Radiological Health. (2019). Ingested, transient, space occupying device for weight management and/or weight loss (DEN180060).

Vivus LLC. (2023). Qsymia (phentermine and topiramate extended-release capsules), for oral use, CIV [package insert].

GoodRx Health has strict sourcing policies and relies on primary sources such as medical organizations, governmental agencies, academic institutions, and peer-reviewed scientific journals. Learn more about how we ensure our content is accurate, thorough, and unbiased by reading our editorial guidelines.

Was this page helpful?

Subscribe and save.

Get prescription saving tips and more from GoodRx Health. Enter your email to sign up.

By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.

5 Wegovy Alternatives to Consider for Weight Loss - GoodRx (2024)
Top Articles
Latest Posts
Article information

Author: Velia Krajcik

Last Updated:

Views: 5897

Rating: 4.3 / 5 (54 voted)

Reviews: 93% of readers found this page helpful

Author information

Name: Velia Krajcik

Birthday: 1996-07-27

Address: 520 Balistreri Mount, South Armand, OR 60528

Phone: +466880739437

Job: Future Retail Associate

Hobby: Polo, Scouting, Worldbuilding, Cosplaying, Photography, Rowing, Nordic skating

Introduction: My name is Velia Krajcik, I am a handsome, clean, lucky, gleaming, magnificent, proud, glorious person who loves writing and wants to share my knowledge and understanding with you.